IMRAN MIR A 4

What Happened Imran Mir, listed as a 10% owner of Rani Therapeutics (RANI), was granted a derivative award on 2026-05-28 covering 123,600 shares. The award shows an acquisition price of $0.00 (no cash paid at grant) and is reported as an award/grant (transaction code A). This is a grant of an option-like award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-28; Form 4 filed 2026-06-01.
• Amount: 123,600 shares granted; reported acquisition price $0.00; total reported cash value $0.
• Vesting: Per footnote, the shares subject to the option vest in full on the first anniversary of the grant subject to continuous service, or earlier upon the company's next annual stockholder meeting or a Change in Control.
• Shares owned after transaction: Not stated in the filing.
• Transaction type: Derivative award (grant of option/option-like award). No immediate exercise or sale reported.

Context This filing reports an award (grant) rather than a purchase or sale, so it does not represent immediate market buying or selling. The award vests in the future and may accelerate on defined corporate events; therefore no shares were necessarily transferable or sold at the time of the report. As a reported 10% owner, Imran Mir is a significant shareholder—this is insider reporting of a compensation/ownership grant, not a routine open-market trade.